FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 118_S_5502.
Which chamber initiated this legislation?
This legislation was initiated in the Senate.
When did the legislative process begin?
The process officially started on 2024-12-12.
What are the main provisions?
Key points include:
- Streamlining Medicare coverage to ensure new enrollees maintain access to their existing diabetes technology (e.g., CGMs, pumps) during the first 12 months of enrollment.
- Requiring Medicare to separately cover the critical software and algorithms used in automated insulin delivery systems, promoting innovation and beneficiary access.
- Expanding access to diabetes self-management training, removing limits on duration or quantity if deemed medically necessary by a healthcare professional.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Sen. Shaheen, Jeanne [D-NH].
What is the latest detailed status?
The latest detailed status is: Introduced in Senate
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.
What is the impact of this bill?
We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.